Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dexlansoprazole 30mg MR Capsules
Therapeutic Category
Gastroenterology, Antacid
Dosage Form
capsule
Packaging Type
Alu Alu
Packaging
10*10
Price
₹179/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Lanzotyle DX 30 Capsules contains Dexlansoprazole 30 mg (Modified Release), a proton pump inhibitor (PPI) that helps reduce the production of stomach acid. It is primarily used for treating acid-related disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. By controlling excessive acid secretion, it helps in relieving heartburn, acid reflux, and associated discomfort.
Dexlansoprazole works by blocking the proton pumps in the stomach lining, preventing the release of acid. Unlike traditional PPIs, Dexzrol 30 features a modified-release formulation, ensuring prolonged action and sustained symptom relief throughout the day. This formulation is beneficial for individuals who experience acid reflux, indigestion, or heartburn that persists despite lifestyle modifications.
Regular use of Lanzotyle DX 30 Capsules aids in healing esophageal damage caused by stomach acid and prevents ulcers from recurring. It is also useful for patients with Zollinger-Ellison Syndrome, a condition associated with excessive stomach acid production.
May cause nausea, diarrhea, headache, abdominal pain, flatulence, or dizziness. Long-term use may lead to bone fractures, vitamin B12 deficiency, or magnesium imbalance.
Used to treat GERD, erosive esophagitis, peptic ulcers, and other acid-related disorders.
Consult a doctor before use, especially if pregnant, breastfeeding, or taking other medications. Avoid prolonged use without medical supervision to prevent potential complications.
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
Composition : Lansoprazole (15mg) Tablet
Composition : Lansoprazole (30mg)
Composition : Omeprazole (20mg) Capsule
Composition : Pantoprazole (20mg)
Composition : Pantoprazole (40mg) Injection
Composition : Pantoprazole (40mg)
Composition : Pantoprazole (80mg) Dual Release Gastro-Resistant
Composition : Pantoprazole (40mg) + Itopride (150mg)
Composition : Rabeprazole I.P. 20mg
Composition : Rabeprazole (20mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Dexzrol 30 Capsule, containing Dexlansoprazole 30mg MR, has strong demand in the gastroenterology and acid reflux management segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their gastrointestinal care portfolio.
Medical distributors and agencies can benefit from the consistent market demand for proton pump inhibitors used in GERD, acidity, heartburn, and gastric ulcer management. Dexzrol 30 Capsule helps strengthen a comprehensive gastro care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Dexzrol 30 Capsule with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted gastrointestinal care product range when partnering for Dexzrol 30 Capsule distribution.
Medical distributors, stockists, and wholesalers interested in Dexzrol 30 Capsule can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.